MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Pharmaceutical Development and Clinical Trials (Facts & Figures)
2018: The top 15 pharma companies by 2017 revenue
Amgen Inc. (NASDAQ:AMGN)
*Key People: Amgen
Parents
*Key People: Industry (Medical)
Amgen Inc. (NASDAQ:AMGN)
Children
2023: Amgen Downsizes by 300 Amid Industry Constriction_ biospace
David Reese, MD, Executive Vice President and Chief Technology Officer, Amgen (2024)
Dr Leroy Hood, MD, Phd, President, Institute of Systems Biology (2026)
Fond farewell to the biotech industry’s founding father (2010)
Gilles Gnacadja, PhD, Executive Director, AI Product Design and Early Development, Amgen (2025)
Glenna Shen, Head of Advocacy Relations, General Medicine, Amgen (2020)
Greg Friberg VP, GLOBAL DEVELOPMENT, AMGEN INC. (2021)
Jay Bradner, M.D. Executive Vice President, Research and Development, and Chief Scientific Officer, Amgen (2024)
Joseph Miletich, SVP, Research and Development, Amgen
Kevin Sharer, CEO, Chairman
Murdo Gordon, Amgen Inc. - Executive VP of Global Commercial Operations (2021)
Nancy Hopkins Emerita Amgen Inc. professor of biology, Biology Department and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (2025)
Number of employees: 26,700 (2023)
P.K. Morrow, MD Vice President of Clinical Development, Amgen Oncology (2020)
Robert A. Bradway, Amgen Inc. - Chairman, CEO & President (2021)
Robert Stoffel, VP of Rare Disease, Complex Biologics, and Strategic Technology Alliance, Amgen (2024)
Tracy Lahey Strategy & Business Development, Digital Health & Innovation at Amgen (2023)
Jumps
Denny Lanfear, CEO, Intekrin
Dr Roger Perlmutter, Director, R&D, Merck, University of Washington, former, Amgen (2015)
Finance & Acquisitions: Amgen
Organization & Developments: Amgen